CTXR
Citius Pharmaceuticals Inc
Price:  
3.06 
USD
Volume:  
122,327.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CTXR WACC - Weighted Average Cost of Capital

The WACC of Citius Pharmaceuticals Inc (CTXR) is 7.7%.

The Cost of Equity of Citius Pharmaceuticals Inc (CTXR) is 11.75%.
The Cost of Debt of Citius Pharmaceuticals Inc (CTXR) is 5.00%.

Range Selected
Cost of equity 9.90% - 13.60% 11.75%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.8% - 8.6% 7.7%
WACC

CTXR WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.31 1.56
Additional risk adjustments 0.0% 0.5%
Cost of equity 9.90% 13.60%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.8% 8.6%
Selected WACC 7.7%